Symrise (FRA:SY1) has been given a €73.00 ($84.88) target price by stock analysts at Independent Research in a research note issued to investors on Thursday. The brokerage presently has a “neutral” rating on the stock. Independent Research’s price target indicates a potential upside of 1.36% from the company’s current price.
Several other research analysts have also commented on the company. Morgan Stanley set a €75.00 ($87.21) price target on Symrise and gave the stock a “neutral” rating in a research report on Wednesday, August 29th. Societe Generale set a €91.00 ($105.81) price target on Symrise and gave the stock a “buy” rating in a research report on Monday, August 27th. Goldman Sachs Group set a €58.20 ($67.67) price target on Symrise and gave the stock a “sell” rating in a research report on Monday, September 3rd. Hauck & Aufhaeuser set a €75.00 ($87.21) price target on Symrise and gave the stock a “neutral” rating in a research report on Friday, August 31st. Finally, UBS Group set a €82.00 ($95.35) price target on Symrise and gave the stock a “neutral” rating in a research report on Tuesday, September 25th. Three equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of €74.09 ($86.15).
SY1 opened at €72.02 ($83.74) on Thursday. Symrise has a 52 week low of €56.96 ($66.23) and a 52 week high of €73.48 ($85.44).
Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.
Recommended Story: Trading Penny Stocks
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.